Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

62.80
BATS BZX Real-Time Price
As of 11:52am ET
 -0.21 / -0.33%
Today’s Change
47.97
Today|||52-Week Range
64.00
+18.89%
Year-to-Date
Bristol-Myers Squibb misses mark with cancer drug
8:42am / FT.com - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
Intermediate Trade: Merck
7:36am / TheStreet.com - Paid Partner Content
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors
Aug 23 / TheStreet.com - Paid Partner Content
Cramer: The 'Just You Wait' Crowd Keeps Waiting
Aug 29 / TheStreet.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
Gilead Was Smart to Let Medivation Slip Through its Fingers
Aug 29 / GuruFocus News - Paid Partner Content
2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now
Aug 18 / MotleyFool.com - Paid Partner Content
The EpiPen Scandal Is Worse Than You Think: What Youre Not Being Told
Aug 27 / Investing Channel - Paid Partner Content
Gilead: breaking the fever
Aug 17 / FT.com - Paid Partner Content
US Stocks Lower Friday With Hawkish Tone From Fed
Aug 26 / GuruFocus News - Paid Partner Content
Pfizer's Bold Bid to Conquer Cancer
Aug 16 / MotleyFool.com - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Stocks are hot again. But are they too hot?
Aug 16 / CNNMoney.com
Tight Trading on Thursday with Stocks Ending Lower
Aug 25 / GuruFocus News - Paid Partner Content
Allergan setback prompts healthcare slide
Aug 08 / FT.com - Paid Partner Content
3 Reasons Gilead Sciences Inc. Stock Could Fall
Aug 25 / MotleyFool.com - Paid Partner Content
Bristol-Myers' value plunges $23bn after cancer drug fails trial
Aug 05 / FT.com - Paid Partner Content
Healthcare Drug Pricing a Factor for the Market on Wednesday
Aug 24 / GuruFocus News - Paid Partner Content